{
    "organizations": [],
    "uuid": "9d60a2d229cfaaa8db7752904cb9885873e817ac",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biolinerx-announces-grant-of-europ/brief-biolinerx-announces-grant-of-european-patent-covering-use-of-bl-8040-with-cytarabine-idUSFWN1SN0MT",
    "ord_in_thread": 0,
    "title": "BRIEF-Biolinerx Announces Grant Of European Patent Covering Use Of Bl-8040 With Cytarabine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 16 (Reuters) - BioLine RX Ltd:\n* BIOLINERX ANNOUNCES GRANT OF EUROPEAN PATENT COVERING USE OF BL-8040 WITH CYTARABINE FOR TREATING ACUTE MYELOID LEUKEMIA Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-16T19:36:00.000+03:00",
    "crawled": "2018-05-17T14:38:27.036+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "bioline",
        "rx",
        "ltd",
        "biolinerx",
        "announces",
        "grant",
        "european",
        "patent",
        "covering",
        "use",
        "cytarabine",
        "treating",
        "acute",
        "myeloid",
        "leukemia",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}